SML4008
Zuclopenthixol
≥98% (HPLC)
Synonym(s):
(Z)-4-[3-(2-chloro-9H-thioxanthen-9-ylidene)propyl]-1-piperazineethanol, 4-[(3Z)-3-(2-Chloro-9H-thioxanthen-9-ylidene)propyl]-1-piperazineethanol
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Empirical Formula (Hill Notation):
C22H25ClN2OS
CAS Number:
Molecular Weight:
400.96
UNSPSC Code:
12352200
MDL number:
NACRES:
NA.21
SMILES string
S1c2c(cc(cc2)Cl)\C(=C/CCN4CCN(CC4)CCO)\c3c1cccc3
InChI key
WFPIAZLQTJBIFN-DVZOWYKESA-N
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
-10 to -25°C
Quality Level
Biochem/physiol Actions
Oral and potent antagonist of D1/D2 dopamine receptors, α1-adrenergic receptors and 5-HT2 receptors.
Zuclopenthixol, a typical antipsychotic, is an oral and potent antagonist of D1/D2 dopamine receptors, α1-adrenergic receptors and 5-HT2 receptors. Zuclopenthixol is approved in some countries for treatment of schizophrenia and other psychoses. Zuclopenthixol is a cis isomer of neuroleptic clopenthixol.
Zuclopenthixol, a typical antipsychotic, is an oral and potent antagonist of D1/D2 dopamine receptors, α1-adrenergic receptors and 5-HT2 receptors. Zuclopenthixol is approved in some countries for treatment of schizophrenia and other psychoses. Zuclopenthixol is a cis isomer of neuroleptic clopenthixol.
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Zuclopenthixol decanoate for schizophrenia and other serious mental illnesses
Cochrane database of systematic reviews (Online) null
Elham Sardari et al.
Multiple sclerosis and related disorders, 73, 104622-104622 (2023-03-24)
Multiple sclerosis (MS) is an autoimmune neurodegenerative disease affecting numerous people worldwide. While the relapsing subtypes of MS are to some extent treatable, the disease remains incurable leading to progressive disability. Limited efficacy of current small molecule drugs necessitates development
Jianjun Li et al.
Journal of oncology, 2022, 5490461-5490461 (2022-01-25)
Esophagus cancer (ESCA) is the sixth most frequent cancer in males, with 5-year overall survival of 15%-25%. RNA modifications function critically in cancer progression, and m6A regulators are associated with ESCA prognosis. This study further revealed correlations between m6A and
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service